← Back to Clinical Trials
Recruiting NCT07282691
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
Trial Parameters
Condition MTBI - Mild Traumatic Brain Injury
Sponsor Salus University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 18 Years
Max Age 35 Years
Start Date 2025-04-01
Completion 2028-09-29
Brief Summary
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of mTBI within previous 1 to 6 months * Distance visual acuity better than or equal to 20/25 in each eye * Score \>21 on Convergence Insufficiency Symptom Survey Exclusion Criteria: * Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness * Not wearing required refractive error) * Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination) * Cognitive delays that may impact testing